Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2020-12-17 | New | $13,000,000 | $13,000,000 | Equity Only | 06b | SEC link |
| 2020-02-11 | New | $35,000,000 | $35,000,000 | Equity Only | 06b | SEC link |
| 2016-03-09 | New | $4,250,000 | $4,250,000 | Equity Only | 06b | SEC link |
| 2015-09-21 | New | $21,585,401 | $21,585,401 | Equity Only | 06b | SEC link |
| 2015-03-11 | New | $450,015 | $450,015 | Equity Only | 06b | SEC link |
| 2015-03-09 | New | $10,196,546 | $10,196,546 | Equity Only | 06b | SEC link |
| 2015-01-28 | New | $57,500,000 | $57,500,000 | Equity Only | 06b | SEC link |
| 2014-08-22 | New | $28,634,166 | $28,634,166 | Equity Only | 06b | SEC link |
| 2014-04-10 | New | $24,999,943 | $24,999,943 | Equity Only | 06b | SEC link |
| 2013-05-15 | Amended | $150,000,000 | $85,590,658 | Equity Only | 06 | SEC link |
| 2013-03-18 | New | $64,409,342 | $64,409,342 | Equity Only | 06 | SEC link |
| 2012-11-15 | New | $25,000,002 | $25,000,002 | Equity Only | 06 | SEC link |
| 2012-04-26 | Amended | $75,000,006 | $25,000,003 | Equity Only | 06 | SEC link |
| 2012-01-24 | Amended | $50,000,003 | $33,000,003 | Equity Only | 06 | SEC link |
| 2012-01-09 | New | $17,000,000 | $17,000,000 | Equity Only | 06 | SEC link |
| 2011-11-14 | New | $1,092,344 | $1,092,344 | Equity Only | 06 | SEC link |
| 2011-09-14 | New | $17,000,004 | $17,000,004 | Equity Only | 06 | SEC link |
| 2011-06-08 | New | $91,825,055 | $91,825,055 | Equity Only | 06 | SEC link |
| 2011-05-11 | New | $550,001 | $550,001 | Equity Only | 04 | SEC link |
| 2011-04-22 | Amended | $66,936,470 | $10,982,502 | Equity Only | 06 | SEC link |
| 2011-02-18 | Amended | $55,953,968 | $18,447,254 | Equity Only | 06 | SEC link |
| 2011-02-09 | New | $1,013,625 | $1,013,625 | Equity Only | 06 | SEC link |
| 2010-11-12 | Amended | $37,506,714 | $20,102,813 | Equity Only | 06 | SEC link |
| 2010-03-05 | New | $17,403,901 | $17,403,901 | Equity Only | 06 | SEC link |
| 2010-01-05 | New | $25,000,000 | $25,000,000 | Equity Only | 06 | SEC link |
| 2009-06-29 | New | $9,999,999 | Unknown | Equity Only | 06 | SEC link |
| 2008-04-24 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2007-05-30 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2006-09-12 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2006-03-09 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Cesar L. Alvarez | Director |
| Robert P. Beech | Executive |
| Jack A. Bobo | Executive |
| Samuel Broder | Executive |
| Sunil Chada | Executive |
| Grace E. Colon | Executive |
| Ena Chan Cratsenburg | Executive |
| Matthew B. Crisp | Executive |
| Matt Crisp | Executive |
| Steven Frank | Director |
| Gregory I. Frost | Executive |
| Tom Goralski | Executive |
| Vinita D. Gupta | Director |
| Fred Hassan | Director |
| Ronald B. Herberman | Executive |
| Larry D. Horner | Director |
| Kelly Huang | Executive |
| Corey Huck | Executive |
| Olivier R. Jarry | Executive |
| Timothy D. Kasbe | Executive |
| Thomas R. Kasser | Executive |
| Jeffrey B. Kindler | Director |
| Randal J. Kirk | Director |
| Krish S. Krishnan | Executive |
| Suma M. Krishnan | Executive |
| Donald P. Lehr | Executive |
| Joel D. Liffman | Executive |
| Joel D. Liffmann | Executive |
| Nick Macris | Executive |
| Dean J. Mitchell | Director |
| Glenn Nedwin | Executive |
| Nir Nimrodi | Executive |
| Jeffrey Perez | Executive |
| Marcelo Quiroga | Executive |
| Thomas D. Reed | Executive |
| Thomas Reed, Ph.D. | Executive |
| Jayson M. Rieger | Executive |
| Helen Sabzevari, Ph.D. | Director, Executive |
| Robert B. Shapiro | Director |
| Burton Sobel | Director |
| Rick L. Sterling | Executive |
| James S. Turley | Director |
| Joseph L. Vaillancourt | Executive |
| Robert F. Walsh, Iii | Executive |
| Darryl Webster | Executive |
| David J. Zaccardi | Director |
| Gerardo A. Zapata | Executive |
| Saiid Zarrabian | Executive |